Search results
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks via Yahoo Finance· 2 days agoThe Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE)...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 5 days agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
3 Stocks That Can Help You to Get Richer in 2025 and Beyond
Motley Fool via Yahoo Finance· 1 day ago(For example, it helps drug companies manage their clinical trials.) Its myriad customers include...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters via Yahoo News· 23 hours agoNovavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators...
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 3 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs that tried to...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 3 days agoShares of vaccine producers' stocks are trading higher Wednesday on reports indicating disease...
Arbutus, Novavax See Activist Investor Action
Barrons.com· 22 hours agoMcElhaugh’s statement that Arbutus doesn’t anticipate further at-the-market share issuances this year due to its substantial...
Cleburne rebounds from four runs down to end RedHawks' win streak
The Fargo Forum· 15 hours agoCleburne rallied from four runs down to defeat Fargo-Moorhead 9-5 on Friday at La Moderna Field. The...
Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 3 days agoVaccine manufacturers Novavax and Pfizer said via email they planned to assess their accessibility...